Steroid Use May Blunt Anti-PD-1 Effect in NSCLC
(MedPage Today) -- Lower response rate, PFS, survival with ?10 mg/day baseline dose
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news
More News: Endocrinology | Non-Small Cell Lung Cancer